Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Phase II Study of Enzalutamide With Radiation Therapy for Intermediate Risk Prostate Cancer: A Phase 2 StudyInt. J. Radiat. Oncol. Biol. Phys 2021 Feb 23;[EPub Ahead of Print], GJ Bubley, I Kaplan, R Bhatt, ME Taplin, S Dowling, K Mahoney, E Werner, EP Nguyen
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.